Table 2.
Clinical model | EMR model | |||
---|---|---|---|---|
Covariates | Hazard ratio* (95% CI) |
Points | Hazard ratio* (95% CI) |
Points |
Age | ||||
65–69 | REF | 0 | REF | 0 |
70–74 | 0.87 (0.53, 1.42) | 0.91 (0.56, 1.49) | ||
75–79 | 1.09 (0.69, 1.72) | 1.18 (0.74, 1.86) | 1 | |
80–84 | 1.16 (0.73, 1.87) | 1 | 1.31 (0.82, 2.11) | |
85–89 | 1.78 (1.11, 2.87) | 2 | 2.19 (1.35, 3.54) | 3 |
90+ | 1.77 (1.01, 3.10) | 2.43 (1.40, 4.20) | ||
Gender | ||||
Male | 1.75 (1.40, 2.19) | 2 | 1.73 (1.38, 2.17) | 2 |
Comorbidity | ||||
COPD | 1.59 (1.23, 2.06) | 2 | 2.03 (1.57, 2.62) | 3 |
CHF | 1.61 (1.17, 2.19) | 2 | 1.91 (1.40, 2.60) | 2 |
Pneumonia | 1.94 (1.56, 2.41) | 2 | NI† | NI |
Home oxygen use in prior 24 months |
1.68 (1.02, 2.76) | 2 | NI | NI |
Functional | ||||
Any difficulty dressing yourself | 1.42 (1.04, 1.93) | 1 | NA‡ | NA |
Difficulty walking a half- mile | ||||
Some difficulty | 1.33 (0.98, 1.80) | 1 | NA | NA |
Much difficulty/cannot do | 1.44 (1.08, 1.91) | NA | NA | |
Behavioral | ||||
History of alcohol- related aggressive behavior |
1.69 (1.12, 2.54) | 2 | NA | NA |
Body mass index | ||||
<18.5 | 1.39 (0.76, 2.54) | 1 | 1.41 (0.77, 2.60) | 1 |
18.5 to <25 | REF | 0 | REF | 0 |
25 to <30 | 0.75 (0.58, 0.95) | −1 | 0.77 (0.60, 0.98) | −1 |
30 to <35 | 0.69 (0.49, 0.97) | 0.78 (0.56, 1.09) | ||
≥35 | 0.45 (0.25, 0.81) | −3 | 0.54 (0.30, 0.96) | −2 |
Pharmacy | ||||
Inhaled corticosteroid | 1.49 (1.05, 2.12) | 1 | 1.75 (1.21, 2.51) | 2 |
Oral corticosteroid | 1.87 (1.32, 2.66) | 2 | 2.22 (1.56, 3.15) | 3 |
C-index (95% CI) Development cohort |
0.72 (0.70, 0.75) | 0.72 (0.69, 0.75) |
0.69 (0.67, 0.72) | 0.69 (0.66, 0.72) |
C-index (95% CI) Validation cohort |
0.70 (0.66, 0.73) | 0.69 (0.66, 0.73) |
0.69 (0.66, 0.73) | 0.69 (0.66, 0.73) |
Estimate from the Fine and Gray model, also known as a proportional sub-distribution hazards model (see Supplemental Methods)
NI = Not included in final model
NA = Not applicable (i.e. variable not expected to be available in EMR)